BRIEF-EMA Advises Against Use Of COVID-19 Vaccine Janssen In People With History Of Capillary Leak Syndrome

* EMA: EMA ADVISES AGAINST USE OF COVID-19 VACCINE JANSSEN IN PEOPLE WITH HISTORY OF CAPILLARY LEAK SYNDROME:

* EMA SAYS COMMITTEE ALSO RECOMMENDED THAT CAPILLARY LEAK SYNDROME SHOULD BE ADDED TO THE PRODUCT INFORMATION AS A NEW SIDE EFFECT OF JANSSEN VACCINE * EMA - COMMITTEE REVIEWED 3 CASES OF CAPILLARY LEAK SYNDROME IN PEOPLE WHO GOT COVID-19 VACCINE JANSSEN, WHICH OCCURRED WITHIN 2 DAYS OF VACCINATION

* EMA SAYS COMMITTEE ASKED JANSSEN FOR FURTHER INFORMATION ABOUT POSSIBLE MECHANISM FOR DEVELOPMENT OF CAPILLARY LEAK SYNDROME FOLLOWING VACCINATION Further company coverage: